Build 'Oxyscan AI'—a $50K/year SaaS + hardware platform combining microfluidic chips, edge AI, and cloud analytics to enable point-of-care oxidative stress testing. The platform would: 1) Deploy disposable microfluidic chips with embedded sensors to detect ROS (reactive oxygen species) in real-time (e.g., 'Sample #XYZ: 85% oxidative stress—flag for drug trial'); 2) Provide a 'Biomarker Dashboard' showing drug response curves (e.g., 'Drug A reduces oxidative stress by 60% in 2 hours'); 3) Integrate with ELN/LIMS systems (e.g., Benchling) to auto-populate research data; 4) Offer a 'Trial Optimization Score' showing cost savings (e.g., 'Switching to Oxyscan could save $1.5M/year per trial').

Market Catalyst & News Trigger

"Oxidative Stress Assay Market Size to Reach USD 3.25 Billion by 2035 | SNS Insider"

The Workflow Friction

Biopharma companies, CROs, and academic labs

Problem Summary

Real-world problem signal validation.

One-Shot MVP Builder Blueprint (48 Hours)

A dashboard showing: 1) Real-time oxidative stress readings (e.g., 'Patient #452: High oxidative stress—recommend antioxidant therapy'); 2) Drug response curves (e.g., 'Drug X: 70% reduction in 4 hours'); 3) Trial cost savings (e.g., 'Current assay cost: $500/test—Oxyscan reduces to $5/test'); 4) Integration status with ELN/LIMS (e.g., 'Benchling: Connected—auto-populate data').

Recommended Developer Tech Stack

• Vue.js
• Python (for edge AI)
• PostgreSQL
• AWS IoT Greengrass
• TensorFlow Lite